3 top (and cheap!) growth stocks I’d buy right now

Royston Wild discusses three terrific growth shares that he thinks could make you richer.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Compass pointing towards 'best price'

Image source: Getty Images.

UDG Healthcare (LSE: UDG) is a share that’s delivered some pretty great double-digit-percentage earnings growth in recent years.

City analysts expect growth to slow in the current period. In the 12 months to September 2019, a 3% rise is being predicted. But the FTSE 250 firm is expected to crank up the pace again from 2020. A 10% advance is pencilled in for then.

5 Stocks For Trying To Build Wealth After 50

One notable billionaire made 99% of his current wealth after his 50th birthday. And here at The Motley Fool, we believe it is NEVER too late to start trying to build your fortune in the stock market. Our expert Motley Fool analyst team have shortlisted 5 companies that they believe could be a great fit for investors aged 50+ trying to build long-term, diversified portfolios.

Click here to claim your free copy now!

UDG is a pretty great growth share to snap up, in my opinion. As a provider of a broad range of outsourced services, like distribution and packaging production, to pharmaceutical and healthcare companies, it has strong exposure to the kind of defensive sector that allows earnings to grow almost each and every year. And thanks to its strong balance sheet, it has the capabilities to build its global base via more M&A to give profits growth that extra boost.

Build a fortune

Right now UDG trades fractionally above the benchmark forward P/E ratio of 15 times that indicates decent value. That’s stunning value for a firm with such a robust growth outlook, in my opinion, but if you’re looking for even cheaper then Grafton Group Units (LSE: GFTU) is worth a serious look.

This FTSE 250 firm deals on a prospective earnings multiple of 12.1 times and, like the aforementioned medical star, also has a history of hot bottom-line growth over the past several years. It’s been able to prove itself as a reliable profits generator thanks to its exposure to foreign climes, the building materials supplier offsetting weakness in the UK with strong growth elsewhere.

Indeed, on these shores Grafton saw sales rise just 3.4% in the three months to December, but in The Netherlands and Belgium these increased 3.6% and 7.4% respectively. And in Ireland these jumped by a staggering 9.8% because of the ripping expansion in the country’s construction industry.

A breath of fresh air

It’s little wonder then that City brokers are predicting additional earnings expansion of 4% in 2018 and 6% next year. And I’m confident that its broad geographic base and strong market conditions therein can keep profits bounding higher.

Another great growth pick to load up on today is Porvair (LSE: PRV). The filtration technologies expert is going from strength to strength and in the last fiscal year (the 12 months ending November 2018), revenues hit record highs of £128.8m, up 11% year-on-year and a result that reflected the quality of its specialist products.

Another reason why the small-cap’s profits column has ripped relentlessly higher, and is expected to continue to do so with rises of 5% predicted for both fiscal 2019 and 2020, is the company’s appetite for acquisitions. It made two major purchases last year, taking total spend on capital projects and M&A over the past five years to £42m, and it has the financial strength to keep its chequebook glowing.

An admission: Porvair’s forward P/E ratio of 20.7 times isn’t exactly cheap on paper. I would argue, though, that the firm’s highly-successful, aggressive growth strategy makes it a steal even at current prices.

Is this little-known company the next ‘Monster’ IPO?

Right now, this ‘screaming BUY’ stock is trading at a steep discount from its IPO price, but it looks like the sky is the limit in the years ahead.

Because this North American company is the clear leader in its field which is estimated to be worth US$261 BILLION by 2025.

The Motley Fool UK analyst team has just published a comprehensive report that shows you exactly why we believe it has so much upside potential.

But I warn you, you’ll need to act quickly, given how fast this ‘Monster IPO’ is already moving.

Click here to see how you can get a copy of this report for yourself today

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK owns shares of Porvair. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Senior woman wearing glasses using laptop at home
Investing Articles

SSE shares are up 15% since the market correction! Should I buy?

Jabran Khan looks at why SSE shares have been on an upward trajectory in recent weeks and decides if he…

Read more »

One English pound placed on a graph to represent an economic down turn
Investing Articles

After crashing 29%, Spectris shares look cheap to me

After peaking at 4,167p last September, Spectris shares have slumped by over 29%. But I see deep value in the…

Read more »

British Pennies on a Pound Note
Investing Articles

Here is why I added this dirt-cheap FTSE 100 penny stock to my holdings!

Jabran Khan explains why he added this dirt-cheap FTSE 100 stock to his holdings and is excited by its recovery…

Read more »

Woman looking at a jar of pennies
Investing Articles

3 FTSE 100 penny stocks! Which is the cheapest buy?

Our writer examines three penny stocks that feature in the FTSE 100 index to ascertain whether they have a place…

Read more »

Arrowings ascending on a chalkboard
Investing Articles

Is the Vodafone share price an opportunity at current levels?

Jabran Khan looks at the current Vodafone share price and decides if he would add the shares to his holdings…

Read more »

Smiling senior white man talking through telephone while using laptop at desk.
Investing Articles

4 gems I’d include in my Stocks & Shares ISA

Jon Smith explains some of the top stocks he's thinking about including in his Stocks and Shares ISA a we…

Read more »

Compass pointing towards 'best price'
Investing Articles

At 85p, are Rolls-Royce shares a no-brainer buy? 

The Rolls-Royce share price look very cheap right now. And I think this might be my last chance to buy…

Read more »

positive mental health woman
Investing Articles

My £3-a-day blue-chip passive income plan

Our writer sets out his passive income plan of investing a few pounds each day in top stocks.

Read more »